We updated the design of this site on September 25th. Learn more.
Show more
ClinicalTrials.gov
ClinicalTrials.gov Menu

Study of Integrity of Down Inhibitor Bundle at Patients Suffering of Neuropathic Pain (PhyDoNe)

This study has been completed.
Sponsor:
ClinicalTrials.gov Identifier:
NCT01053845
First Posted: January 21, 2010
Last Update Posted: July 8, 2014
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
Collaborator:
Grünenthal GmbH
Information provided by (Responsible Party):
University Hospital, Clermont-Ferrand
January 19, 2010
January 21, 2010
July 8, 2014
April 2010
May 2011   (Final data collection date for primary outcome measure)
Comparison of the amplitude of N2P2 waves between healthy volunteers and patients suffering of peripheral neuropathic pain.
Same as current
Complete list of historical versions of study NCT01053845 on ClinicalTrials.gov Archive Site
Not Provided
Not Provided
Not Provided
Not Provided
 
Study of Integrity of Down Inhibitor Bundle at Patients Suffering of Neuropathic Pain
Study of Integrity of Down Inhibitor Bundle at Patients Suffering of Neuropathic Pain

Several studies showed that activity of down inhibitor bundle is weakened in different painful pathologies as the fibromyalgy or the trigeminal nevralgy.

The purpose of the protocol is to study the working of down inhibitor bundle at patients suffering of neuropathic pain.

Prospective study with comparison groups
Interventional
Phase 1
Allocation: Non-Randomized
Intervention Model: Parallel Assignment
Masking: None (Open Label)
Primary Purpose: Diagnostic
  • Healthy Volunteers
  • Patients Suffering of Peripheral Neuropathic Pain
Other: Neuropathic pain
to study the working of down inhibitor bundle at patients suffering of neuropathic pain
Not Provided
Not Provided

*   Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline.
 
Completed
20
May 2011
May 2011   (Final data collection date for primary outcome measure)

Inclusion Criteria:

  • neuropathic patients group

    • Patient suffering of peripheral neuropathic pain
    • 18 years old women or men at least

Exclusion Criteria:

  • • Healthy volunteers

    • 18 years old women or men at least
Sexes Eligible for Study: All
18 Years and older   (Adult, Senior)
Yes
Contact information is only displayed when the study is recruiting subjects
France
 
 
NCT01053845
CHU-0066
2009-A00155-52 ( Registry Identifier: ID RCB )
Not Provided
Not Provided
Not Provided
University Hospital, Clermont-Ferrand
University Hospital, Clermont-Ferrand
Grünenthal GmbH
Principal Investigator: Gisèle Pickering, Dr University Hospital, Clermont-Ferrand
University Hospital, Clermont-Ferrand
July 2014

ICMJE     Data element required by the International Committee of Medical Journal Editors and the World Health Organization ICTRP